Variable | Mean Value | Distribution (parameters) | 95% C.I. based on parameters |
---|---|---|---|
IVIG Response Rate | 0.473 | beta (α = 35.52,β = 39.61) | (0.361, 0.585) |
IVIG relapse rate (25 weeks) | 0.13 | beta (α = 4.03, β = 26.97) | (0.039, 0.266) |
IVIG incremental utility | 0.12 | normal (μ = 0.12,β = 0.08) | (-0.05, 0.29) |
Corticosteroid adverse events annual probailites | Â | Â | Â |
   Fracture | 0.0098 | beta (α = 1.20,β = 120.8) | (0.000,0.033) |
   Diabetes mellitus | 0.0043 | beta (α = 0.48,β = 111.52) | (0.000,0.022) |
   Cataract | 0.0114 | beta (α = 1.39,β = 120.61) | (0.001,0.036) |
   Glaucoma | 0.0008 | beta (α = 0.09,β = 111.91) | (0.000,0.008) |
   Serious Infection | 0.0035 | beta (α = 0.39,β = 120.8) | (0.000,0.020) |
Glaucoma utility weight | 0.96 | beta (α = 214.32, β = 13.68) | (0.906,0.967) |
Cataract utility weight-before surgery | 0.62 | beta (α = 62, β = 38) | (0.586,0.767) |
Cataract utility weight post-surgery | 0.90 | beta (α = 90, β = 10) | (0.835,0.951) |
Glaucoma utility weight | 0.96 | beta (α = 214.32, β = 13.68) | (0.906,0.967) |